Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
about
The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMVCytomegalovirus post kidney transplantation: prophylaxis versus pre-emptive therapy?The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ TransplantationInfection in Organ Transplantation.Current characteristics and outcome of cytomegalovirus infections after kidney transplantation.Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.Emerging cytomegalovirus management strategies after solid organ transplantation: challenges and opportunities.Cytomegalovirus infection in liver transplant recipients: updates on clinical managementThe efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.The swiss transplant cohort study: lessons from the first 6 years.Expanding role of cytomegalovirus as a human pathogen.Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting.The Cell Biology of Cytomegalovirus: Implications for Transplantation.Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.A potential role for cytomegalovirus in a facial ulcer in a renal transplant recipient.Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome.Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients.Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.Clinical Experience with Immune Monitoring for Cytomegalovirus in Solid-Organ Transplant Recipients.
P2860
Q26768481-99DF6D6D-27F8-4937-BBE0-13566797D564Q28082017-25DC1CD3-8D45-469A-85F2-19C24740FDE4Q28085440-8A1A1F42-AAE0-4221-B383-225C97D92A9DQ30238810-F8EE3F52-5BFC-45A0-B937-96BD8630D808Q33416126-9908E23D-89EF-495A-8B1D-527F5F932D8DQ36071675-E039BCEB-F4B6-4AA6-BB6C-67A7A0451F73Q38225475-2D9BD642-E6D2-4BAB-BD44-D8CF87D7CB5CQ38242802-CC07A49B-E6CA-48B7-8D23-9C9D39C03641Q38254037-DB65EB83-614F-450A-A050-E9DE3B1167CFQ38444815-0CB72C5C-B6E5-4212-9D1F-625A7DAD37D2Q38673038-298D98DC-A420-4120-9D01-F467EFD29146Q38733949-FC28CEDE-6E2C-456C-BA51-C0FBD479486AQ38779938-DDFB8754-BBC0-4376-AD2D-CE9DC2D73160Q38875887-DACE40E1-840F-4F33-BED8-22DFF0A4A037Q40389617-B9826FA3-4F63-4EEC-B4E0-451452D15756Q40731516-F6B909CB-1CD6-4C9C-8665-8A6CBED18CEBQ40763966-42D1317C-698D-4008-A42D-4274122D0AE4Q40880029-AB1959DD-B5CA-473B-AF37-DA3F2316FF7FQ41177320-10B39AC4-5FC3-48A2-B194-E8C8B3BBDE1DQ41342348-CC47A0CF-8680-45FC-AF87-A395719B6CDFQ41660745-A1A46C09-8DB8-4192-99A8-87F06CB0BB81Q42206830-F93DCFB0-A881-4591-9BF5-C6A077DFE51AQ42216221-8BB98520-7C80-4E6A-AD48-BB262B77380FQ42246073-5292CDE0-368D-4658-97A3-567E02D8E9B8
P2860
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Impact of antiviral preventive ...... d organ transplant recipients.
@en
Impact of antiviral preventive ...... d organ transplant recipients.
@nl
type
label
Impact of antiviral preventive ...... d organ transplant recipients.
@en
Impact of antiviral preventive ...... d organ transplant recipients.
@nl
prefLabel
Impact of antiviral preventive ...... d organ transplant recipients.
@en
Impact of antiviral preventive ...... d organ transplant recipients.
@nl
P2093
P2860
P356
P1476
Impact of antiviral preventive ...... d organ transplant recipients.
@en
P2093
C van Delden
G Kralidis
H H Hirsch
M T Koller
N J Mueller
P2860
P304
P356
10.1111/AJT.12388
P407
P577
2013-08-05T00:00:00Z